Patent Assignment
Reel/Frame 059357/0545
Change of Name
Recorded: 2022-03-09
Pages: 4
Assignor
STEMIMMUNE, INC.
Executed: 2018-05-24
Assignee
CALIDI BIOTHERAPEUTICS, INC.
10210 CAMPUS POINT DRIVE, SUITE 150, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Combination Immunotherapy Approach for Treatment of Cancer
Application:
17/689,643 →
Publication:
US US20220241388A1
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2022
From: SZALAY, ALADAR; MINEV, BORIS
To: STEMIMMUNE, INCORPORATED
Reel/Frame 059214/0775 →
Merger
Mar 9, 2022
From: CALIDI BIOTHERAPEUTICS, INC.
To: CALIDI BIOTHERAPEUTICS, INC.
Reel/Frame 059214/0829 →
Change of Name
May 1, 2024
From: CALIDI BIOTHERAPEUTICS, INC.
To: CALIDI BIOTHERAPEUTICS (NEVADA), INC.
Reel/Frame 067285/0965 →